Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus
暂无分享,去创建一个
H. Kiem | C. Peterson | P. Becker | J. Adair | Sara P. Kubek | Blake J. Rust | Devikha Chandrasekaran | Christopher W. Peterson
[1] Anthony E. Boitano,et al. Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning , 2020, Molecular therapy. Methods & clinical development.
[2] J. Soulier,et al. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia , 2019, Nature Medicine.
[3] I. Weissman,et al. Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. , 2019, Cell stem cell.
[4] Y. Takeuchi,et al. Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery , 2019, Molecular therapy. Nucleic acids.
[5] D. Scadden,et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation , 2019, Nature Communications.
[6] H. Kiem,et al. Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A , 2018, Haematologica.
[7] Y. Takeuchi,et al. Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins , 2018, Journal of Virology.
[8] W. J. Ramsey,et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine , 2017, The New England journal of medicine.
[9] J. Wagner,et al. Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations , 2017, Expert review of hematology.
[10] Thomas M. Schmitt,et al. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] Otto-Wilhelm Merten,et al. Production of lentiviral vectors , 2016, Molecular therapy. Methods & clinical development.
[12] S. Vogel,et al. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance , 2015, Proceedings of the National Academy of Sciences.
[13] B. Sandmaier,et al. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. , 2014, Blood.
[14] S. Russell,et al. Vesiculovirus Neutralization by Natural IgM and Complement , 2014, Journal of Virology.
[15] A. Oxenius,et al. VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications , 2014, Journal of Virology.
[16] M. Betjes,et al. Activation‐induced CD137 is a fast assay for identification and multi‐parameter flow cytometric analysis of alloreactive T cells , 2013, Clinical and experimental immunology.
[17] P. Kurre,et al. Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles , 2013, PloS one.
[18] D. Schaffer,et al. Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors , 2013, Gene Therapy.
[19] A. Figuera,et al. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. , 2011, Blood.
[20] Songbin Fu,et al. A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus* , 2010, The Journal of Biological Chemistry.
[21] Yong Zhao,et al. 2-Gy whole-body irradiation significantly alters the balance of CD4+CD25− T effector cells and CD4+CD25+Foxp3+ T regulatory cells in mice , 2010, Cellular and Molecular Immunology.
[22] H. Kiem,et al. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[23] K. Karwacz,et al. HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7 , 2010, Journal of Virology.
[24] A. Annoni,et al. Immune responses to lentiviral vectors. , 2007, Current gene therapy.
[25] P. Greenberg,et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.
[26] Zhengfan Jiang,et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. , 2007, Virology.
[27] P. Kurre,et al. Prolonged Adherence of Human Immunodeficiency Virus-Derived Vector Particles to Hematopoietic Target Cells Leads to Secondary Transduction In Vitro and In Vivo , 2006, Journal of Virology.
[28] Mario Roederer,et al. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles , 2005, Nature Medicine.
[29] Xian-Yang Zhang,et al. LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .
[30] P. Sinn,et al. Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production , 2005, Gene Therapy.
[31] A. Auerbach. Diagnosis of Fanconi Anemia by Diepoxybutane Analysis , 2003, Current protocols in human genetics.
[32] P. Sheridan,et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] I. Chen,et al. Lentiviral Vectors--the Promise of Gene Therapy Within Reach? , 1999, Science.
[34] T Friedmann,et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Pierce,et al. SUBLETHAL FRACTIONATED TOTAL‐BODY IRRADIATION AND DONOR BONE MARROW INFUSION FOR INDUCTION OF ALLOGRAFT TOLERANCE , 1985, Transplantation.
[36] W. Wara. Immunosuppression associated with radiation therapy. , 1977, International journal of radiation oncology, biology, physics.
[37] B. Fields,et al. Human infection with the virus of vesicular stomatitis during an epizootic. , 1967, The New England journal of medicine.
[38] F. Issa. Selective Hematopoietic Stem Cell Ablation Using CD117-Antibody-drug-conjugates Enables Safe and Effective Transplantation With Immunity Preservation , 2019 .
[39] David A. Williams,et al. Stem Cell Collection and Gene Transfer in Fanconi Anemia. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.